AU771901B2 - Methods and compositions for increasing intestinal absorption of fats - Google Patents

Methods and compositions for increasing intestinal absorption of fats Download PDF

Info

Publication number
AU771901B2
AU771901B2 AU57052/99A AU5705299A AU771901B2 AU 771901 B2 AU771901 B2 AU 771901B2 AU 57052/99 A AU57052/99 A AU 57052/99A AU 5705299 A AU5705299 A AU 5705299A AU 771901 B2 AU771901 B2 AU 771901B2
Authority
AU
Australia
Prior art keywords
fatty acid
lysophosphatidylcholine
monoglyceride
agent
isolated complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU57052/99A
Other languages
English (en)
Other versions
AU5705299A (en
Inventor
David W. Yesair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomolecular Products Inc
Original Assignee
Biomolecular Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Products Inc filed Critical Biomolecular Products Inc
Publication of AU5705299A publication Critical patent/AU5705299A/en
Application granted granted Critical
Publication of AU771901B2 publication Critical patent/AU771901B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004—Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU57052/99A 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats Ceased AU771901B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08
US60/099430 1998-09-08
PCT/US1999/020427 WO2000013689A1 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats

Publications (2)

Publication Number Publication Date
AU5705299A AU5705299A (en) 2000-03-27
AU771901B2 true AU771901B2 (en) 2004-04-08

Family

ID=22274976

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57052/99A Ceased AU771901B2 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats

Country Status (13)

Country Link
US (1) US6426069B1 (https=)
EP (1) EP1119360B1 (https=)
JP (1) JP4700193B2 (https=)
CN (1) CN1321089A (https=)
AT (1) ATE347371T1 (https=)
AU (1) AU771901B2 (https=)
CA (1) CA2343116C (https=)
DE (1) DE69934325T2 (https=)
IL (2) IL141801A0 (https=)
NO (1) NO20011173L (https=)
NZ (1) NZ510536A (https=)
WO (1) WO2000013689A1 (https=)
ZA (1) ZA200102268B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161178A0 (en) * 2001-10-11 2004-08-31 Biomolecular Products Inc MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
DE60238663D1 (de) 2002-04-05 2011-02-03 Nestle Sa Zusammensetzungen und Verfahren zur Verbesserung von Lipidassimilation in Haustieren
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
JP2006518384A (ja) * 2003-01-31 2006-08-10 チルドレンズ・ホスピタル・ロス・アンジエルス 改善されたバイオアベイラビリティを有するフェンレチニドの経口組成物、およびその使用方法
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) * 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
US10463229B2 (en) * 2010-10-22 2019-11-05 Fukuoka University Endoscopic observation method and composition for improving diagnostic performance involving applying useful white opaque substance to diagnosis of gastric epithelial tumors (adenoma or gastric cancer)
CA2817957C (en) * 2010-11-15 2016-05-10 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
AU2019342421B2 (en) * 2018-09-21 2024-09-05 Société des Produits Nestlé S.A. Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)
WO2025148196A1 (zh) * 2024-01-12 2025-07-17 小藻科技(安吉)有限公司 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
ES2071332T3 (es) 1990-08-13 1995-06-16 David W Yesair Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias.
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
JPH11506780A (ja) * 1995-06-06 1999-06-15 バイオモレキュラー プロダクツ，インク． 薬またはカロリー送達用の混合脂質−重炭酸塩コロイド粒子
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
WO1998010776A1 (en) * 1996-09-11 1998-03-19 Shanahan Prendergast Elizabeth Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms

Also Published As

Publication number Publication date
DE69934325D1 (de) 2007-01-18
US6426069B1 (en) 2002-07-30
WO2000013689A1 (en) 2000-03-16
ZA200102268B (en) 2001-09-19
EP1119360A4 (en) 2003-06-04
CN1321089A (zh) 2001-11-07
IL141801A (en) 2009-02-11
CA2343116C (en) 2008-11-18
NO20011173D0 (no) 2001-03-07
JP4700193B2 (ja) 2011-06-15
ATE347371T1 (de) 2006-12-15
JP2002524417A (ja) 2002-08-06
NZ510536A (en) 2003-07-25
NO20011173L (no) 2001-05-08
EP1119360B1 (en) 2006-12-06
CA2343116A1 (en) 2000-03-16
EP1119360A1 (en) 2001-08-01
AU5705299A (en) 2000-03-27
IL141801A0 (en) 2002-03-10
DE69934325T2 (de) 2007-07-05

Similar Documents

Publication Publication Date Title
CN100418519C (zh) 用于增强认知能力的含有花生四烯酸或其与二十二碳六烯酸的组合的组合物
US7807718B2 (en) Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
US6699496B1 (en) Enzyme in a dosage form for oral use in mammals, enzyme-containing food material and method for administering the enzyme in a dosage form
ES2369074T3 (es) Composiciones que tienen efectos preventivos o mejoradores de síntomas o enfermedades provocados por una hipofunción cerebral.
Jensen et al. The lipolytic triad human lingual, breast milk, and pancreatic lipases: physiological implications of their characteristics in digestion of dietary fats
AU771901B2 (en) Methods and compositions for increasing intestinal absorption of fats
KR20030016306A (ko) 지방산의 치료용 조합
KR20040004652A (ko) 조효소 ｑ 및 에이코사펜타에노산（ｅｐａ）
JPH08193028A (ja) ヘリコバクターの阻害
KR102830519B1 (ko) Lpc-dha 및 lpc-epa가 풍부한 크릴 오일 조성물
WO2008149177A2 (en) Marine lipid compositions and uses thereof
JP3467794B2 (ja) 学習能向上剤
JPWO2008062559A1 (ja) 栄養補助食品、抗疲労作用剤又は持久力増強剤、機能性食品又は化粧料
Hayes et al. Review of triacylglycerol digestion, absorption, and metabolism with respect to SALATRIM triacylglycerols
US20080058286A1 (en) Novel applications of omega-3 rich phospholipids
CN1756544A (zh) 使超昼夜节律正常化的花生四烯酸的用途
EP1106181A1 (en) Nutritional compositions for preventing or treating hyperlipoproteinemia
CN1345188A (zh) 含七碳脂肪酸甘油三酯的营养补充剂或药物制剂
US7842679B2 (en) Phospholipid derivatives of DHA and methods for treating respiratory failure using the same
Tamargo et al. Pharmacokinetics and safety profile of omega-3 polyunsaturated fatty acids
JPH06271464A (ja) 消化器系障害の予防または治療用アラキドン酸含有組成物
Chen et al. Docosahexaenoic acid-containing phospholipids and triglycerides based nutritional supplements
US20030032672A1 (en) Method for preparing a conjugated linoleic acid-containing structured lipid and use of the same
JPS62111926A (ja) コリン作働性神経系活性化剤
Staggers Lipid digestion and absorption in the suckling rat.

Legal Events

Date Code Title Description
SREP Specification republished
FGA Letters patent sealed or granted (standard patent)